Comparison of the prognostic potential of biomechanic stress markers - circulating stromelysin-1, matrix metalloprteinase-9 and N-terminal fragment of brain natriuretic peptide in patients with acute Q-wave myocardial infarction. Results of cohort study
DOI:
https://doi.org/10.14739/2310-1237.2012.1.15859Keywords:
matrix metalloproteinases, N-terminal fragment of brain natriuretic peptide, myocardial infarction, prognosisAbstract
85 patients after documented Q-wave myocardial infarction (MI) were observed. Echocardiography was performed and circulating levels of such biomarkers as MMP-3, MMP-9 and NT-pro-BNP were detected on the day of hospitalization and diagnosis of acute IM, on 21 and 60 days after onset of acute MI. The analysis of revealed data has shown that increase of MMP-3 and MMP-9 above optimal cut-point (9.7 ng/ml and 18.1 ng/ml respectively) was closely associated with up of 1-year cardiovascular mortality risk in patients after
Q-MI. Used in prognostic model analysis of content of circulating MMP-3 and MMP-9 is corelated with increase of positive prognostic value of both of them rising up to 70% (prognostic sensitivity and specify are 84% and 82% respectively).
References
A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month post discharge death in an international registry / Eagle K.A., Lim M.J., Dabbous O.H. [et al.] // JAMA. – 2004. – Vol. 291. – P. 2727–2733.
Acute heart failure syndromes: current state and framework for future research / Gheorghiade M., Zannad F., Sopko G., Klein L. // Circulation. – 2005. – Vol. 112. – P. 3958–3968.
Asmi M.H. A practical guide to echocardiography / M.H. Asmi, M.J. Walsh. – London: Chapman & Hall Medical, 1995. – 260 p.
Chan D. Biomarkers in acute myocardial infarction / Chan D., Ng L.L. // BMC Med. – 2010. – Vol. 8. – P. 34–39.
Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9 or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure / George J., Patal S., Wexler D. [et al.] // Am. Heart J. – 2005. – Vol. 150. – P. 484–487.
Circulating Stromelysin-1 (MMP-3): a novel predictor of LV dysfunction, remodelling and all-cause mortality after acute myocardial infarction / Kelly D., Cockerill G., Ng L.L. [et al.] // Eur. J. Heart Fail. – 2009. – Vol. 10, №2. – P. 133–139.
Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction / Smilde T.D., van Veldhuisen D.J., Navis G. [et al.] // Circulation. – 2006. – Vol. 114. – P. 1572–1580.
Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18 / Morrow D.A., de Lemos J.A., Sabatine M.S. [et al.] // J. Am. Coll. Cardiol. – 2003. – Vol. 41. – P. 1264–1272.
Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction / Van den Borne S.W., Cleutjens J.P., Hanemaaijer R. [et al.] // Cardiovasc. Pathol. – 2009. – Vol. 18. – P. 37–43.
Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population / McDonagh T.A., Cunningham A.D., Morrison C.E. [et al.] // Heart. – 2001. – Vol. 86. – P. 21–26.
Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction / White H.D., Norris R.M., Brown M.A. [et al.] // Circulation. – 1987. – Vol. 76. – P. 44–51.
Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples / Mueller T., Gegenhuber A., Dieplinger B. [et al.] // Clin. Chem. Lab. Med. – 2004. – Vol. 42. – P. 942–944.
Macdonald S. P. Rapid risk stratification in suspected acute coronary syndrome using serial multiple cardiac biomarkers: a pilot study / Macdonald S.P., Nagree Y. // Emerg. Med. Australas. – 2008. – Vol. 20, №5. – P. 403–409.
Matrix metalloproteinase expression in cardiac myocytes following myocardial infarction in the rabbit / Romanic A.M., Burns-Kurtis C.L., Gout B. [et al.] // Life Sci. – 2001. – Vol. 68. – P. 799–814.
Matrix metalloproteinase inhibition after myocardial infarction: A new approach to prevent heart failure? / Creemers E.E., Cleutjens J.P., Smits J.F., Daemen M. J. // Circ. Res. – 2001. – Vol. 89. – P. 201–210.
Matrix metalloproteinase-2 predicts mortality in patients with acute coronary syndrome / Dhillon O.S., Khan S.Q., Narayan H.K. [et al.] // Clin. Science. –2010. – Vol. 118. – P. 249–257.
Mori S. Differential expression of MMPs and TIMPs in moderate and severe heart failure in a transgenic model / Mori S., Gibson G., McTiernan C. F. // J. Card. Fail. – 2006. – Vol. 12. – P. 314–325.
N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes / Omland T., Persson A., Ng L. [et al.] // Circulation. – 2002. – Vol. 106. – P. 2913–2918.
N-terminal pro-B-type natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndrome / Khan S.Q., Narayan H., Ng K.H. [et al.] // Clin. Sci. – Lond., 2009. – Vol. 117. – P. 31–39.
Pfeffer M.A. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications / Pfeffer M. A., Braunwald E. // Circulation. – 1990. – Vol. 81. – P. 1161–1172.
Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome / Inokubo Y., Hanada H., Ishizaka H. [et al.] // Am. Heart J. –2001. – Vol. 141. – P. 211–217.
Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease / Wu T.C., Leu H.B., Lin W.T. [et al.] // Eur. J. Clin. Invest. – 2005. – Vol. 35. – P. 537–545.
Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study / Kelly D., Cockerill G., Ng L.L. [et al.] // Eur. Heart J. – 2007. – Vol. 28. – P. 711–718.
Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction / Squire I.B., Evans J., Ng L.L. [et al.] // J. Card. Fail. – 2004. – Vol. 10. – P. 328–333.
Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes / Omland T., de Lemos J.A., Morrow D.A. [et al.] // Am. J. Cardiol. – 2002. – Vol. 89. – P. 463–465
Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction / Hama N., Itoh H., Shirakami G. [et al.] // Circulation. – 1995. – Vol. 92. – P. 1558–1564.
Relationships between plasma levels of matrix metalloproteinases and neurohormonal profile in patients with heart failure / Yan A.T., Yan R.T., Spinale F.G. [et al.] // Eur. J. Heart Failure. – 2008. – Vol. 10. – P. 125–128.
Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling / Webb C.S., Bonnema D.D., Ahmed S.H. [et al.] // Circulation. – 2006. – Vol. 114. – P. 1020–1027.
Sun Y. Myocardial repair/remodelling following infarction: roles of local factors / Sun Y. // Cardiovasc Res. – 2009. – Vol. 81. – P. 482–490.
Thygesen K. Universal Definition of Myocardial Infarction / Thygesen K., Alpert J.S., White H.D. on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction // Circulation. – 2007. – Vol. 116. – P. 2634–2653.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
